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OriginalClinical ScienceçGeneralCombined Ex Vivo Hypothermic and Normothermic
Perfusion for Assessment of High-risk Deceased
Donor Human Kidneys for Transplantation
Sandra K. Kabagambe, MD,1 Ivonne P. Palma,1 Yulia Smolin,1 Tristan Boyer,1 Ivania Palma,1
Junichiro Sageshima, MD,1 Christoph Troppmann, MD,1 Chandrasekar Santhanakrishnan, MD,1
John P. McVicar, MD,1 Kuang-Yu Jen, MD, PhD,2 Miriam Nuño, PhD,3 and Richard V. Perez, MD1Background.Despite careful clinical examination, procurement biopsy and assessment on hypothermic machine perfusion, a
significant number of potentially useable deceased donor kidneys will be discarded because they are deemed unsuitable for trans-
plantation. Ex vivo normothermic perfusion (EVNP) may be useful as a means to further assess high-risk kidneys to determine
suitability for transplantation.Methods. From June 2014 to October 2015, 7 kidneys (mean donor age, 54.3 years and Kidney
Donor Profile Index, 79%) that were initially procured with the intention to transplant were discarded based on a combination of
clinical findings, suboptimal biopsies, long cold ischemia time (CIT) and/or poor hypothermic perfusion parameters. They were
subsequently placed on EVNP using oxygenated packed red blood cells and supplemental nutrition for a period of 3 hours.
Continuous hemodynamic and functional parameters were assessed.Results.After a mean CITof 43.7 hours, all 7 kidneys
appeared viable on EVNP with progressively increasing renal blood flow over the 3-hour period of perfusion. Five of the 7 kidneys
had excellent macroscopic appearance, rapid increase in blood flow to 200 to 250 mL/min, urine output of 40 to 260 mL/h and
increasing creatinine clearance.Conclusions. Favorable perfusion characteristics and immediate function after a 3-hour course
of EVNP suggests that high-risk kidneys subjected to long CIT may have been considered for transplantation. The combined use
of ex vivo hypothermic and normothermic perfusion may be a useful strategy to more adequately assess and preserve high-risk
kidneys deemed unsuitable for transplantation. A clinical trial will be necessary to validate the usefulness of this approach.
(Transplantation 2019;103: 392–400)The number of patients on the waiting list for renal trans-plantation far exceeds the number of organs available
for transplantation. Efforts to address the organ shortage
have resulted in expansion of the donor pool to include do-
nors with acute kidney injury, increase risk of infection trans-
mission, donation after circulatory death (DCD), and older
donors or those with other defined comorbidities, previously
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392 www.transplantjournal.comcandidates on the waitlist have reported a willingness to ac-
cept ECD kidneys1 and a survival advantage has been dem-
onstrated with transplantation of ECD and higher risk
kidneys.2-4 Despite the severe organ shortage and survival
advantage of transplantation, many kidneys procured with
the intent to transplant are discarded.
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ment biopsy findings9,10 have been developed to better assess
organ quality and match appropriate organs to suitable re-
cipients yet the use of these tools may not correlate with graft
survival and lead to unnecessary kidney discards.11,12 Indeed,
the percentage of procured kidneys discarded in the United
States has increased from 5.1% to 19.2% over 2 decades,
with 3159 kidneys discarded in 2015.13
As the demand for organs has increased, the use of hypo-
thermic machine perfusion (HMP) has been used to assess
and preserve high-risk kidneys.14-17 The use of hypothermic
perfusion in the United States has progressively increased in
recent years, particularly for high-risk kidneys as defined by
Kidney Donor Profile Index (KDPI),18 a quantitative mea-
sure of the quality of deceased donor kidneys (DDKs) relative
to other kidneys recovered. Hypothermic machine perfusion
is associated with a reduced risk of delayed graft function
(DGF) and graft failure when compared to cold storage15,16
and flow characteristics onmachine perfusion have been used
to determine suitability for transplantation.16,17 Hypothermic
perfusion is therefore commonly used as an additional tool to
assess and preserve high-risk kidneys before transplantation.
Ex vivo normothermic perfusion (EVNP) of organs has re-
cently been shown to be an effective means of assessing, pre-
serving and possibly expanding the number of extrarenal
organs available for transplantation.19-22 ENVP may be su-
perior in comparison to hypothermic perfusion when it is
used to evaluate suitability for transplantation as it allows
assessment of viability and function of the metabolically
active organ during perfusion. Presently, Hosgood and
Nicholson23-26 in the United Kingdom have the only clini-
cal reports using a brief 1-hour period of EVNP before re-
nal transplantation. Renal EVNP has not been reported in
the United States, but its potential to expand the donor
pool may be significant, considering the large number of po-
tentially transplantable organs currently being discarded. If
this modality is to be used in the United States, differences
in practice patterns here need to be consideredwhen compared
with the use of EVNP in the United Kingdom where preserva-
tion is predominantlywith cold storage and preservation times
short. Incorporation of EVNP into clinical practice in the
United States may need to take into account allocation policy
and clinical practice characterized by regional sharing of or-
gans across large geographic areas, longer cold preservation
time, and the common use of hypothermic perfusion for
high-risk organs. The objective of this study is to determine
whether a 3-hour course of EVNP would be useful to assess
high-risk DDKs that have been exposed to a prolonged cold
ischemia time (CIT) and a period of assessment on HMP.
MATERIALS AND METHODS
Deceased Donor Kidneys
From June 2014 toOctober 2015, our center conditionally
accepted 445 kidneys for transplantation from both our local
and distant organ procurement organizations (OPOs). After
an initial period of cold static storage at the originating
OPO the kidneys were transported to our transplant center
and placed on HMP (RM3 System;WatersMedical Systems,
Rochester, MN) using Kidney Perfusion Solution-1 (Organ
Recovery System, Itaca, IL) with 40 international units of in-
sulin and 19 mL of 20% mannitol with the intention toproceedwith transplantation.After assessment, 380 kidneyswere
transplanted and 65 were determined to be “nontransplantable”
and were discarded. Seven of the 65 nontransplantable kidneys
had research consent from the originating OPO and were
entered in this study.
The study protocol was considered exempt by our institu-
tional review board and subsequently approved by the Hu-
man Anatomical Specimen and Tissue Oversight Committee.
Parameters for Suitability for Transplantation
Before EVNP
Based on overall assessment after hypothermic perfusion,
the transplant surgeon made the ultimate decision to trans-
plant or discard the organ. Generally, kidneys deemed unsuit-
able for transplantation at our institution have biopsy findings
of greater than 20% glomerulosclerosis and moderate-to-
severe vascular changes, hypothermic pump flow less than
70 mL/min, and renal resistive index greater than
0.50 mm Hg/mL per minute after a period of 4 to 6 hours
on hypothermic perfusion. None of these individual exclu-
sion criteria are necessarily considered absolute but were in-
cluded along with donor factors, total ischemic time, and
appropriateness for the intended recipient when making
the decision to proceed with transplantation.
Ex Vivo Normothermic Perfusion System
OurEVNPcircuit (Figure 1) is similar to the systemdescribed
by Hosgood25,26 consisting of a pediatric cardiopulmonary
bypass system comprised of a centrifugal blood pump (550
Bio-Console and BP-50 Bio-Pump, Medtronic, Minneapolis,
MN), heat exchanger (Bio Cal 370,Medtronic), hollow fiber
oxygenator with a hard shell reservoir (CX*RX05RW;
Terumo Cardiovascular, Ann Arbor, MI), pressure display
box and probe (Model 66000; Medtronic), and flow bio-
probe (Model TX50P;Medtronic). The kidneys were housed
in a stainless-steel platform and perfused at an arterial pressure
between 70 and 80 mm Hg for 3 hours at a temperature of
37°C. Flowwas adjusted to keep the arterial pressure between
the set points.
Composition of EVNP Perfusate
Blood type O packed red blood cells obtained by our hos-
pital blood bank was diluted at a 1:1 ratio with Plasma-Lyte
A (Baxter Medical) to which was added 2000 international
units of heparin sodium (NOVAPLUS) and exogenous anhy-
drous creatinine (0.06 g; MP Biomedicals, LLC). The EVNP
circuit was primed with 500 mL of this perfusate which was
oxygenated with 95% O2/5% CO2 and supplemented with
parenteral nutrition (Baxter CLINIMIX E 2.75/10) fortified
with 100 units of regular insulin (Humulin R), 5 mL of
multivitamins (Baxter Infutive Adult), and 26 mL of 8.4%
sodium bicarbonate (Hospira, Inc, Lake Forest, IL) per liter
of solution to keep perfusate within a 7.3 to 7.4 range, and
this solution was added to the perfusate at a rate of 20 mL
per hour. During perfusion Plasma-Lyte A was added every
30 minutes to match urine output at a 1:1 ratio.
Kidney Assessment While on EVNP
Kidneys were monitored continuously by observance of
global appearance, renal blood flow (RBF)/resistance, and
urine output whichwas recorded every 30minutes.Measure-
ments of glucose, lactate, and creatinine were done using Stat
Sensors (Nova Biomedical Corp.). Arterial blood gas, venous
FIGURE 1. Ex vivo normothermic perfusion circuit. After priming the circuit, the perfusate flows into the kidney via renal arterial cannula.
Venous blood passively flows from the renal vein into a reservoir. A centrifugal pump circulates the venous perfusate to the oxygenator
and heater/cooler. Flow and pressure probes are used to adjust and maintain mean arterial pressure at 70 to 80 mm Hg. The perfusate
returns to the kidney via the renal arterial cannula. Urine is collected into a beaker via a ureteral catheter.
394 Transplantation ■ February 2019 ■ Volume 103 ■ Number 2 www.transplantjournal.comblood gas, and basic metabolic panel were measured at time 0
(immediately at start of perfusion) and at 30-minute inter-
vals during perfusion (Critical Care Xpress, Nova Biomedical
Corp.). A wedge biopsy of the renal cortex for hematoxylin
and eosin staining was obtained before placement of the kidney
on EVNP and at the completion of the 3-hour perfusion period.
Urine was analyzed for sodium and creatinine for calculation of
creatinine clearance and fractional excretion of sodium (R&D
Systems, Minneapolis, MN, and Critical Care Xpress).
The kidneys were divided into 2 groups based on global
appearance, RBF, and urine output roughly similar to the
criteria previously noted by Hosgood et al.25-27 Kidneys that
on initiation of EVNP perfused uniformly and quickly with a
pink appearance throughout, attained RBF over 150mL/min
and produced urine greater than 20mL/30minutes were des-
ignated as the “optimally perfused” group. Kidneys that had
a slower reperfusion with patchy coloration and areas of
poor perfusion, with blood flow less than 150 mL/min and
urine output less than 20 mL/30 minutes were designated
“non optimally perfused.”
Statistical Analysis
A retrospective analysis of factors that may have contrib-
uted to the decision to discard these kidneys was done to de-
termine potential differences between the non optimally
perfused and optimally perfused groups. The Student t test
and Mann-Whitney U test were both used to emphasize the
validity of the Student t test in assessing group differences in-
volving extremely small sample size with large effect size.28
Effect size and corresponding 95% confidence intervals were
provided for these comparisons. We fit linear mixed-effects
models to compare changes over time in flow, resistance,
urine output, creatinine, lactic acid, and sodium between
the optimally and nonoptimally perfused cohorts. These
models included random effects for intercept and slope toaccommodate correlation of these measures within each case
over time and allow for case-specific rates of change. All tests
were 2-sided and P values less than 0.05 were concluded
statistically significant. Analyses were performed with SAS
software, version 9.4 (SAS Institute, Cary, NC).
RESULTS
Donor Demographics and Characteristics of Kidneys
Seven kidneys that had been discarded after assessment on
HMP underwent EVNP. All 7 kidneys were imported from
outside of our local organ procurement organization. The
mean donor age was 54.3 years (range, 38-65 years; Table 1)
and the mean weight was 80.3 kg (range, 56-100 kg). There
was 1 DCD and 4 ECD donors with mean KDPI of 79%
(range, 53-97%). Most kidneys were discarded because of a
combination of clinical factors, CIT, biopsy findings, and
pump parameters on hypothermic perfusion. The mean
CIT from cross clamp to the start of EVNP was 43.7 hours
(range, 28-64 hours). Final hypothermic perfusion parame-
ters were a mean flow of 72.7 mL/min (range, 59-88 mL/min)
and resistance of 0.41 mm Hg/mL per minute (range, 0.30-
0.52 mm Hg/mL per minute).
Assessment on EVNP
All kidneys at baseline were well flushed with a uniform
pale tan color. With initiation of EVNP the kidneys gradually
warmed up and turned pink, falling into 2 distinct groups based
on macroscopic appearance, RBF, and urine output (Figures 2
and 3). Five kidneys termed “optimally perfused” exhibited
rapid and uniformperfusionwithinminuteswith a healthy pink
color (Figure 2). RBF increased rapidly to a mean rate greater
than 200 mL/min by 30 minutes with a continuous increase
to over 250mL/min by 90minuteswhere flowplateaued. Cor-
respondingly, renal resistive index of the optimally perfused
group fell below 0.40 mm Hg/mL per minute within
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FIGURE 2. Pictures of kidneys before and during ex vivo normothermic perfusion (EVNP). Although their macroscopic appearancewas initially
similar before the start of EVNP, the “optimally perfused” kidneys (n = 5) became globally pink during perfusion and the remaining 2
“nonoptimally perfused” kidneys became pink but were also patchy.
396 Transplantation ■ February 2019 ■ Volume 103 ■ Number 2 www.transplantjournal.com60 minutes and remained low. These kidneys began mak-
ing urine immediately and urine output remained high
throughout the course of EVNP with a total mean urine
output of 144.3 mL/h (range 42.7-269 mL/h, Figure 3).
Two kidneys, termed “nonoptimally perfused,” on initiation
of EVNP did not perfuse uniformly, appearing discolored
with patchy areas of poor perfusion (Figure 2). Renal blood
flow decreased to well below 150 mL/min for the first 60 mi-
nutes of perfusion and renal resistance fell more gradually
when compared to the optimally perfused group. These kid-
neys made very little urine throughout the perfusion period
(0.47 and 3.75 mL/h, respectively). Interestingly, in these
nonoptimally perfused kidneys, blood flow and resistance
stabilized at 90 minutes and continued to improve thereafter
such that by 120 minutes blood flow and resistance was
equal to the optimally perfused group (Figure 3). The opti-
mally perfused kidneys had evidence of superior glomerular
and tubular function with a trend toward increased creati-
nine clearance and lower fractional excretion of sodium
throughout perfusion in comparison to the 2 nonoptimally
perfused kidneys (Figure 3). Perfusate sodium levels had an
increasing trend over time in the optimally perfused group
compared the nonoptimally perfused group which had stable
perfusate sodium levels throughout the perfusion period. The
progressively higher perfusate sodium levels in the optimally
perfused groupwas expected due to the increased urine produc-
tion in this group requiring equivalent volume perfusate replen-
ishment with relatively hypertonic Plasmalyte solution.
Oxygen consumption was calculated as the difference
between arterial and venous oxygen content multiplied
by RBF.29 The optimally perfused kidneys showed a peak
in oxygen consumption within 30 minutes of perfusion after
which consumption decreased and stabilized as shown in
Figure 3. The nonoptimally perfused kidneys showed a
similar oxygen consumption curve but peaked later in the
perfusion period at 120 minutes.
We compared the 2 groups with regard to clinical factors
that may have contributed to the decision to discard these
kidneys as shown in Table 2. Because of the very small sam-
ple size, comparison between groups is based on the geomet-
ric mean (average of log values transformed) rather than the
regular mean.28 No clinical factor that could distinguishbetween the optimally and nonoptimally perfused kidneys
was noted.
Histological analysis revealed that the preperfusion and
postperfusion biopsies of both optimally and nonoptimally
perfused kidneys showed acute tubular injury characterized
by flattening of the tubular epithelial cells with associatedmild
interstitial edema. Compared with the optimally perfused
specimen, the nonoptimal showed more cellular debris, apical
cytoplasmic blebbing and scattered oxalate crystals (Figure 4).DISCUSSION
The decision to use high-risk DDKs is often difficult and
takes into consideration multiple donor and recipient related
factors. Despite the use of all the available modalities a signif-
icant number of potentially useable kidneys are discarded.
We used an EVNP system to assess 7 DDKs that were declined
by all centers after comprehensive assessment including the use
of hypothermic perfusion. Assessment with EVNP subse-
quently demonstrated that the majority of these kidneys had
favorable perfusion appearance, hemodynamic parameters,
urine production and evidence of glomerular and tubular
function. Based on these findings, we suggest that the 5 kid-
neys that had the optimal perfusion characteristics on EVNP
could have been considered for transplantation. The potential
application of EVNP as an assessment tool to evaluate “high-
risk” kidneys currently being discarded will require a clinical
trial as is currently being carried out in the United Kingdom.30
The ultimate usefulness of EVNP to assess high-risk kid-
neys will require the determination of characteristics while
on EVNP that will identify which kidneys are “transplant-
able.” Toward this end, Hosgood assessed 22 discarded kid-
neys on EVNP and demonstrated that the triad of optimal
macroscopic appearance, high blood flow, and high urine
output after 1 hour on EVNP were associated with good
ex vivo glomerular and tubular function27 and retrospec-
tively applied the same scoring system toDDKs that exhibited
improved function after transplantation.25 They also recently
used this EVNP-based scoring system prospectively to assess
and successfully transplant 2 poorly perfused kidneys from a
DCD donor which were declined by all UK centers.26 Interest-
ingly, a recent study from the University of Toronto examined
FIGURE 3. Least square mean of hemodynamic, functional and electrolyte trends on ex vivo normothermic perfusion (EVNP). Overall, for the
“optimally perfused” kidneys, red blood flow (RBF) (mL/min) gradually increased and stabilized after 120 minutes (A) whereas Renal Resistive
Index (RRI) gradually decreased and stabilized after 120 minutes (B). Both RBF and RRI were variable during the first 60 minutes for the
“nonoptimally perfused” kidneys but eventually improved and also stabilized after 120 minutes on EVNP. Urine output (mL/h) remained high
in the “optimally perfused” kidneys (C). Perfusate lactate levels steadily increased with time in the nonoptimally perfused kidneys compared to
relatively stable lactate levels in the perfusate of the optimally perfused group (D). Perfusate sodium levels steadily increased with time in the opti-
mally perfused kidneys compared to relatively stable sodium levels in the perfusate of the nonoptimally perfused group (E). Oxygen consumption
for both kidneys resulted in similar curves with a peak and eventual stable decrease (F). Creatinine clearance (G) and fractional excretion of so-
dium (H) were more favorable in the optimally perfused kidneys.
© 2018 Wolters Kluwer Kabagambe et al 397
TABLE 2.
Retrospective analysis of assessment criteria used to discard the kidneys
Donor history and organ characteristics
Optimally perfused mean
[min-max]
Nonoptimally perfused mean
[min-max]
Effect size (95% CI) PaN = 5 N = 2
Age, y 55.6 [42.0-65.0] 51.0 [38.0-64.0] 0.33 (−1.28 to 2.03) 0.75 0.67
KDPI, % 81.2 [65.0-97.0] 73.5 [53.0-94.0] 0.35 (−1.26 to 2.06) 0.73 0.57
Terminal creatinine, mg/dL 1.4 [0.60-2.45] 2.4 [0.55-4.34] −0.62 (−2.40 to 0.99) 0.88 1.00
CIT, h 40.8 [28.0-56.0] 51.0 [38.0-64.0] −0.70 (−2.51 to 0.91) 0.56 0.67
Terminal HMP flow, mL/min 72.4 [59.0-88.0] 73.5 [66.0-81.0] −0.08 (−1.73 to 1.51) 0.89 1.00
Terminal HMP RRI 0.41 [0.30-0.52] 0.43 [0.37-0.48] −0.17 (−1.83 to 1.45) 0.75 0.86
Values are given in mean and range.
a Student t test and Mann Whitney U test based on geometric means.
95% CI, 95% confidence interval; CIT, cold ischemia time; HMP, hypothermic machine perfusion; KDPI, Kidney Donor Profile Index; RRI, Renal Resistive Index..
398 Transplantation ■ February 2019 ■ Volume 103 ■ Number 2 www.transplantjournal.comwhether an 8-hour period of EVNPwould be useful in assessing
ischemic injury severity and predicting posttransplant outcomes
in a porcine renal auto-transplant model.31 They found that
intrarenal resistance during EVNP, perfusate pH, lactate clear-
ance and postperfusionAST levels all correlatedwith the degree
of ischemic injury and posttransplant function. In contrast to
the studies by Hosgood, urine output during EVNP was
not associated with graft injury or posttransplant outcomes.
The discrepancy in the 2 studies regarding the utility of urine
output in assessing kidney quality may be explained by differ-
ences in the degree of kidney injury, perfusate composition,
and other factors related to the different perfusion systems
used in the 2 studies. These studies illustrate the need for
clinically validated tools that can be used to assess high-risk
kidneys on EVNP and identify which ones are transplantable.
Little is known about the optimal duration of EVNP of the
kidney. Although the UK clinical series involves EVNP for
1 hour before transplantation, it is possible that a longer
period of perfusion may be more beneficial. One potentialFIGURE 4. Histology of prebiopsy and postbiopsy. Hematoxylin and eos
perfused postperfusion biopsy. C, Nonoptimally perfused preperfusion bio
examples of oxalate crystals, arrow heads represent sloughed epithelial cadvantage of a longer period of perfusion is the ability to
more adequately assess the quality of the kidney and better
differentiate which organs may be safely transplanted.
Blum et al29 has demonstrated in a porcine DCD ex vivo
transplant simulation model that kidneys preserved with
8 hours of EVNP have equivalent preservation of renal
function when compared to HMP. Kaths et al32 showed
that porcine kidneys can be successfully transplanted after
8 hours of EVNP. They demonstrated the most significant
improvement in RBF, resistance, urine output and lactate
clearance occurs over the first 2-3 hours on EVNP, similar
to our findings. A subsequent study from the same investi-
gators showed that preservation of porcine kidneys with
16 hours of continuous EVNP resulted in better allograft
function when compared with kidneys that were preserved
for a brief (1 hour) or intermediate (8 hours) period of
EVNP.33 Interestingly, in our study, even the 2 “nonoptimally
perfused” kidneys that initially had a patchy, poorly perfused
appearance over time showed a steady increase in RBF andin, 20, 2 μm. A, Optimally perfused preperfusion biopsy. B, Optimally
psy. D, Nonoptimally perfused postperfusion biopsy. Arrows represent
ells, and asterisk represent cytoplasmic blebbing.
© 2018 Wolters Kluwer Kabagambe et al 399were equivalent to the optimally perfused group after 3 hours
on EVNP. The optimal duration of EVNP is still to be deter-
mined, but assessment of some high-risk kidneys may require
longer periods of perfusion.
Another potential benefit of increasing the duration of
EVNP is the continuation of reparative processes within the
injured kidney before transplantation. Brasile et al34 have
studied various strategies for repair of both canine and hu-
man kidneys in an ex vivo warm perfusion system. One such
strategy is the ex vivo delivery of growth factors to injured
kidneys where she demonstrated progressively longer periods
of perfusion for 6, 18, and 24 hours resulted in correspond-
ingly time-dependent improvement in cytoskeleton integrity
and DNA repair. Similarly, Kaths et al studied the impact of
a brief (1 hour), intermediate (8 hours) or prolonged (16hours)
period of EVNP in a porcine DCD autotransplant model.
Kidneys that were preserved with intermediate and pro-
longed periods of EVNP had less tubular injury and better
functionwhen comparedwith a brief 1 hour period of EVNP.35
Interestingly, the kidneys that were on EVNP for only 1 hour
showed worse allograft function after transplantation when
compared with the kidneys that were preserved with cold
storage alone, suggesting that a longer period of EVNP was
necessary to observe the presumed benefit of reconditioning
and repair. Lastly, another aspect of injury associated with
cold ischemia is the loss of renal high energy adenosine tri-
phosphate stores which can fall by over 90% after 4 hours
of cold ischemia.36 Animal studies have shown that kidneys
depleted of high-energy substrates after cold ischemia are
replenished of adenosine triphosphate after 2 to 3 hours of
EVNP.37,38 For this reason, we chose to perfuse our kidneys
for 3 hours to provide optimal energy replacement and pos-
sibly extend the injury repair process. Further studies will
need to determine the optimal period of EVNP to balance
the potential risks and benefits associatedwith longer periods
of perfusion as is being explored with other organs.39,40
As the possibility of incorporating EVNP into clinical
practice draws near the most straightforward practical ap-
proach would be implementation after static cold storage as
is currently being tested in the United Kingdom.30 This ap-
proach has the advantage of simplicity, relatively low cost
and ease of transportation to a location where EVNP can
then be initiated. If the duration of cold ischemia can be min-
imized the effectiveness of any intervention aimed at improv-
ing outcomes is increased in view of the cumulative risk of
renal injury and DGF with longer periods of cold storage.41
Application of EVNP after a short period of static cold stor-
age may be difficult in the United States considering the large
geographic donor service areas, allocation complexities, and
regional/national sharing of high KDPI kidneys. An alternate
approach to implementation of EVNP is to use this modality
exclusively after procurement, omitting any cold storage to
avoid potential adverse effects of hypothermia. This approach
was demonstrated in a porcine transplant model where
kidneys that were preserved exclusively with EVNP had
less evidence of cell injury and better early graft function
compared to those that were subjected to any degree of
cold storage combined with EVNP.33 Immediate place-
ment of the organ on EVNP would require the develop-
ment of a portable platform that could be transported to
the donor hospital as is currently practiced with lung,
heart, and liver preservation.21,22,42The application of EVNP after a period of HMP is partic-
ularly relevant currently because of the increasing application
of hypothermic perfusion to high-risk kidneys.18 Hypother-
mic machine perfusion has been used to better assess kidney
quality of organs that would otherwise be discarded based
on donor characteristics alone.43 Clinical studies have also
shown reduction in DGF and primary nonfunction in DDKs
with greater exposure to ischemic damage.16,44-46 Hypother-
mic perfusion has also been used to extend the preservation
period before transplantation.47 The potential synergistic ac-
tions of hypothermic and normothermic perfusion used in
combination is an intriguing possibility to assess high-risk or-
gans, optimize function and extend duration of preservation.
Rijkmans et al,48 more than 3 decades ago, were able to
successfully transplant canine kidneys after 6 days by using
hypothermic perfusion combined with an intermediate 3-hour
period of normothermic perfusion on day 3 of preservation.
The ability to safely extend the preservation period of high-
risk kidneys has the benefit of removing time restraints in
using these organs and expanding the time to identify appro-
priate recipients for transplantation. It will be important to de-
termine whether the combination of both ex vivo hypothermic
and normothermic perfusion is a useful strategy to expand the
number of organs available for transplantation.
This study is limited by several factors including the small
sample size, retrospective design, limited number of parame-
ters followed on EVNP, and the unknown clinical impact of
EVNP since these kidneys were not transplanted. Addition-
ally, the 3-hour period of EVNP may not have allowed all
outcome parameters to reach optimal levels for adequate as-
sessment. The lack of definitive criteria for discarding the kid-
neys in our study and the possible selection bias of individual
surgeons demonstrate the somewhat subjective nature of the
decision process in evaluation of high-risk kidneys. Even
though all of these kidneys were turned down by other cen-
ters before being imported to our center, assessment based
on KDPI, hypothermic perfusion, and biopsy characteristics
in isolation suggests that these organs were possibly of suffi-
cient quality and potentially transplantable if other donor
and recipient factors could have been optimized. Alterna-
tively, the observation that the majority of the kidneys did
well on EVNP may suggest that our current protocol for
assessment of high-risk kidneys is not adequate.
In conclusion, many kidneys procured with the intention
to transplant are discarded based on clinical data, biopsy
findings and assessment of the organ on hypothermic perfu-
sion. ENVP may be an additional tool used to assess high-
risk kidneys. A prospective clinical study will be necessary
to determine the role of EVNP in assessing high-risk kidneys,
including the potential use of this modality in combination
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